Researchers from New York Eye and Ear Infirmary of Mount Sinai, New York, reported that subretinal drusenoid deposits (SDDs) ...

Stephen Tsang, MD, PhD, professor at Columbia University and attending physician at NewYork-Presbyterian Hospital, shared encouraging early findings on the use of optogenetic therapy for patients with ...

Despite the recent attention to the potential of developing and using gene therapy to treat several diseases, the therapy was ...

The Eye Care Network sat down with Rajesh K. Rajpal, MD, ophthalmologist and founder of See Clearly Vision Group in McLean, ...

Dompé was selected by the US Food and Drug Administration (FDA) to participate in the Commissioner’s National Priority ...

The dexamethasone insert effectively treats postoperative inflammation and allergic conjunctivitis, with a favorable safety ...

At the 2025 annual meeting of the American Academy of Ophthalmology, Sunir J. Garg, MD, gave a presentation titled, "Endophthalmitis Sterile or not." In an interview with Ophthalmology Times, he ...

Diana Do, MD, a professor of ophthalmology and vice chair of Clinical Affairs at Stanford University's Byers Eye Institute, presented research on aflibercept 8 mg in treating neovascular age-related ...

Stoke Therapeutics announced 2-year data from the FALCON study, a prospective natural history study in people with autosomal ...

Phase 2 STARLIGHT study participants, particularly those with the macular phenotype, experienced meaningful gains in visual ...

Aurion Biotech has released positive 12-month results from its phase 1/2 CLARA trial evaluating the safety, efficacy, and ...

Glaukos announced that the FDA has approved the new drug application for its topical drug therapy (Epioxa HD/Epioxa) for ...